Samjin Pharmaceutical Co. Ltd.
Industry
- Pharmaceuticals
- OTC, Consumer
- Biotechnology
Latest on Samjin Pharmaceutical Co. Ltd.
AriBio Co., Ltd. is set to become the first South Korean pharma firm to begin a global Phase III clinical development program for a novel drug for Alzheimer’s disease (AD), following an IND approval
While the global biopharma industry saw lackluster deal-making activity in 2022, transactions involving antibody-drug conjugates (ADCs) continued to rise amid the global commercial success of Daiichi
The digital therapeutics era appears set to begin in South Korea as several domestic bioventures are now progressing pivotal clinical trials with pipeline assets while others are nearing regulatory ap
SEOUL - Amid the South Korean biopharmaceutical industry's recent increasing focus on open innovation, more companies in the country are now adopting diverse strategies to strengthen and expand their